Results 11 to 20 of about 48,564 (222)

A hopeful therapy for Niemann-Pick C diseases [PDF]

open access: yesLancet, The, 2017
Not abstract ...
Erickson, Robert P.   +1 more
core   +3 more sources

Tonic prime-boost of STING signalling mediates Niemann–Pick disease type C

open access: yesNature, 2021
Ting-ting Chu   +5 more
semanticscholar   +3 more sources

Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial.

open access: yesLancet, The, 2017
D. Ory   +26 more
semanticscholar   +3 more sources

Methyl-β-cyclodextrin restores impaired autophagy flux in Niemann-Pick C1-deficient cells through activation of AMPK [PDF]

open access: yesAutophagy, 2017
Austin, Christopher P.   +8 more
core   +4 more sources

Health insurance literacy and health services access barriers in Niemann–Pick disease: the patient and caregiver voice

open access: yesOrphanet Journal of Rare Diseases, 2022
Background Major challenges to health care access include low health insurance literacy, prohibitive costs, and insurance barriers. Niemann–Pick disease (NPD), comprising acid sphingomyelinase deficiency (ASMD) and Niemann–Pick type C (NPC), is a group ...
George A. Diaz   +2 more
doaj   +1 more source

Niemann-Pick disease type C with kidney involvement

open access: yesHuman Pathology: Case Reports, 2021
Niemann-Pick disease type C is a lysosomal storage disease characterized by defects in lipid trafficking, typically involving the liver, spleen, and central nervous system. Only rare reports of renal involvement of Niemann-Pick disease have been reported
Aanand A. Patel   +2 more
doaj   +1 more source

Understanding the phenotypic variability in Niemann-Pick disease type C (NPC): a need for precision medicine

open access: yesnpj Genomic Medicine, 2023
Niemann-Pick type C (NPC) disease is a lysosomal storage disease (LSD) characterized by the buildup of endo-lysosomal cholesterol and glycosphingolipids due to loss of function mutations in the NPC1 and NPC2 genes.
Macarena Las Heras   +6 more
semanticscholar   +1 more source

Impacts and Burden of Niemann pick Type-C: a patient and caregiver perspective

open access: yesOrphanet Journal of Rare Diseases, 2021
Background Niemann-Pick disease type C (NPC) is a debilitating condition that impacts patients’ and caregivers’ quality of life (QOL) and reduces the patient’s life expectancy.
Eugen Mengel   +9 more
doaj   +1 more source

Case Report: Be Aware of “New” Features of Niemann–Pick Disease: Insights From Two Pediatric Cases

open access: yesFrontiers in Genetics, 2022
Niemann–Pick disease is a relatively common lysosomal storage disease. Cholestatic liver disease is a typical clinical phenotype of Niemann–Pick disease in infancy. The diagnosis is traditionally based on Niemann–Pick cells in bone marrow smears or liver
Fan Chen   +9 more
doaj   +1 more source

Impact of Intravenous Trehalose Administration in Patients with Niemann–Pick Disease Types A and B

open access: yesJournal of Clinical Medicine, 2022
Background and Aims: Niemann–Pick disease (NPD) types A (NPA) and B (NPB) are caused by deficiency of the acid sphingomyelinase enzyme, which is encoded by the SMPD1 gene, resulting in progressive pathogenic accumulation of lipids in tissues.
M. Mobini   +14 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy